MOBILion Systems specializes in identifying and analyzing challenging molecules that other instruments so far have failed to detect.
MOBILion Systems is a biotechnology company that specializes in identifying and analyzing the most challenging molecules that other instruments fail to detect. Its technology focuses on biologic therapeutics, discovering biomarkers, and improving the accuracy of diagnostic tests.MOBILion’s technology makes it easy to separate, identify, and analyze the most challenging molecules that other instruments fail to detect. The company's analytical instruments provide unprecedented sensitivity, resolution, and throughput that will fuel the development of better therapeutics, the ability to detect disease earlier, and the power to attack diseases at their roots instead of their symptoms.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 13, 2021 | Series C | $60M | 1 | — | — | Detail |
Aug 17, 2020 | Series B | $35M | 1 | — | — | Detail |
Nov 12, 2019 | Series A | $15.40M | 1 | Agilent Technologies | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Agilent Technologies | — | Series C |